企業プロフィール
Biohaven 株価・ニュース・カタリスト
- ティッカー:
- BHVN
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
14.46 USD (-1.23%)
終値
最終更新: 2026年8月17日
1.53B USD
時価総額
株価変動の要因
As of Aug 17, 2026, BHVN closed down 1.23% at $14.46. No new same-company headline was identified in the current news window.
企業概要
事業概要
Biohaven is a biopharmaceutical company focused on neuroscience, immunology, and rare disease. Its business combines commercial assets with a pipeline aimed at multiple specialty indications.
所在地とセクター分類
Biohaven is headquartered in the United States and listed on NASDAQ. It sits in specialty biopharma with a strong neuroscience footprint.
ビジネスモデルの特徴
The company depends on product sales, launch execution, and pipeline expansion across CNS and immune-mediated disease. Investors watch revenue, development milestones, and strategic execution.
バイオ業界での位置付け
Biohaven occupies a premium specialty-biopharma niche within biotech. It has both commercial grounding and catalyst sensitivity, which keeps the stock lively.
今後のカタリスト
- Biohaven’s catalysts are its neuroscience pipeline, especially migraine and related CNS programs, plus any update that broadens the commercial story. The company remains one of the cleaner CNS growth names if execution holds.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。